ArticleMolecular medicine (Cambridge, Mass.)2025

Microbial metabolite 5-formamidoimidazole-4-carboxamide ribotide targets METTL1 to inhibit m7G modification of BRCA1 mRNA to inhibit high-grade serous ovarian cancer.

Lixing Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.